| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 11 | -365K | 100% | $28.03 | -$10.2M |
| Net | -11 | -365K | -100% | -$10.2M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Matthew C. Kapusta | CEO, Managing Director, Director | $10.3M | -$7.36M | -41.7% | Sep 24, 2025 |
| Christian Klemt | Chief Financial Officer | $3.44M | -$428K | -11.1% | Sep 24, 2025 |
| Walid Abi-Saab | Chief Medical Officer | $2.09M | -$34.3K | -1.61% | Jun 27, 2025 |
| Jeannette Potts | Chief Legal Officer | $1.74M | -$144K | -7.61% | Jun 16, 2025 |
| Ricardo Dolmetsch | President, R&D | $1.22M | Sep 18, 2023 | ||
| Robert Gut | Director | $1.1M | -$905K | -45.2% | Nov 6, 2025 |
| Alexander Edward Kuta III | Executive VP, Operations | $674K | Mar 7, 2023 | ||
| Jack Kaye | Director | $620K | -$1.21M | -66.1% | Nov 4, 2025 |
| Pierre Caloz | Chief Operating Officer | $557K | Jun 17, 2024 | ||
| Madhavan Balachandran | Director | $545K | -$30.5K | -5.31% | Jun 20, 2025 |
| Jeremy P. Springhorn | Director | $545K | -$30.5K | -5.31% | Jun 20, 2025 |
| David D. Meek | Director | $494K | -$30.5K | -5.82% | Jun 20, 2025 |
| Leonard Post | Director | $433K | -$30.5K | -6.59% | Jun 20, 2025 |
| Rachelle Suzanne Jacques | Director | $410K | -$30.5K | -6.93% | Jun 20, 2025 |
| Paula Soteropoulos | Director | $104K | Jun 13, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|